• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤药剂师制定的服务计划和临床干预措施。

Service plans and clinical interventions targeted by the oncology pharmacist.

作者信息

Pon D

机构信息

Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

出版信息

Pharm Pract Manag Q. 1996 Apr;16(1):18-30.

PMID:10157737
Abstract

Pharmacists are faced with a changing health care environment where they are being asked to demonstrate "value-added" to patient care. Because of the toxicity, complexity, intensity, and cost of cancer treatment, oncology pharmacists have opportunities to prevent adverse drug reactions, reduce costs, optimize drug regimens, and improve patient outcomes. Programs implemented by pharmacists practicing on a 40-bed adult inpatient oncology unit are described, including (1) chemotherapy quality improvement, (2) treatment of febrile neutropenia, and (3) management of peripheral blood cell transplant patients.

摘要

药剂师面临着不断变化的医疗保健环境,在这种环境中,他们被要求为患者护理展示“附加值”。由于癌症治疗的毒性、复杂性、强度和成本,肿瘤药剂师有机会预防药物不良反应、降低成本、优化药物治疗方案并改善患者预后。本文描述了在一个拥有40张床位的成人肿瘤住院病房工作的药剂师所实施的项目,包括(1)化疗质量改进,(2)发热性中性粒细胞减少症的治疗,以及(3)外周血细胞移植患者的管理。

相似文献

1
Service plans and clinical interventions targeted by the oncology pharmacist.肿瘤药剂师制定的服务计划和临床干预措施。
Pharm Pract Manag Q. 1996 Apr;16(1):18-30.
2
Use of decision analysis to evaluate the costs and benefits of filgrastim (G-CSF) therapy.使用决策分析评估非格司亭(粒细胞集落刺激因子)治疗的成本和效益。
Formulary. 1995 Jul;30(7):394-5, 400-4.
3
Current challenges in European oncology pharmacy practice.欧洲肿瘤药学实践中的当前挑战。
J Oncol Pharm Pract. 2010 Mar;16(1):9-18. doi: 10.1177/1078155209354346. Epub 2009 Dec 16.
4
If there are expert systems and dose checks, why do we still need the clinical pharmacist?如果有专家系统和剂量检查,我们为什么仍然需要临床药剂师?
Pharm Pract Manag Q. 1996 Apr;16(1):50-8.
5
Management of febrile neutropenia in an acute oncology service.急性肿瘤科室中性粒细胞减少伴发热的管理
QJM. 2012 Apr;105(4):327-36. doi: 10.1093/qjmed/hcr217. Epub 2011 Nov 12.
6
[Guidelines for prevention of febrile neutropenia].[发热性中性粒细胞减少症的预防指南]
Acta Med Port. 2008 Jan-Feb;21(1):7-19. Epub 2008 Apr 18.
7
Impact of an oncology pharmacy residency training program on quality improvement initiatives in an oncology center.肿瘤药学住院医师培训项目对肿瘤中心质量改进举措的影响。
Pharm Pract Manag Q. 1996 Apr;16(1):59-65.
8
Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.从粒细胞集落刺激因子改为粒细胞-巨噬细胞集落刺激因子的处方变更对接受骨髓抑制性化疗患者结局的影响。
Pharmacotherapy. 2005 Mar;25(3):372-8. doi: 10.1592/phco.25.3.372.61608.
9
Granulocytic growth factors and cancer-related neutropenia: limited effects.粒细胞生长因子与癌症相关中性粒细胞减少症:效果有限。
Prescrire Int. 2006 Oct;15(85):189-91.
10
The American Society of Clinical Oncology guideline program.美国临床肿瘤学会指南项目
Pharm Pract Manag Q. 1996 Apr;16(1):31-8.

引用本文的文献

1
Impact of clinical pharmacist services on quality adjusted life years in head and neck cancer patients.临床药师服务对头颈部癌症患者生命质量调整年数的影响。
Int J Clin Pharm. 2021 Oct;43(5):1208-1217. doi: 10.1007/s11096-021-01235-0. Epub 2021 Feb 2.
2
[Not Available].[无可用内容]。
Can J Hosp Pharm. 2010 Mar;63(2):119-29. doi: 10.4212/cjhp.v63i2.897.
3
The ten most common adverse drug reactions (ADRs) in oncology patients: do they matter to you?肿瘤患者中十种最常见的药物不良反应:它们与您有关吗?
Support Care Cancer. 2004 Sep;12(9):626-33. doi: 10.1007/s00520-004-0622-5.